Overview

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Status:
Completed

Trial end date:
2005-07-01

Target enrollment:
0

Participant gender:
All

Summary

To evaluate the long-term safety and tolerability of pregabalin in patients with partial seizures.

Phase:

Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Pfizer

Treatments:

Pregabalin

Criteria

Inclusion Criteria:

- Must have met the inclusion criteria for preceding double-blind study

- Have received double-blind study medication and wish to receive open-label pregabalin.

Exclusion Criteria:

- Cannot have absence seizures